Every edition. An expanding view of orthopaedic evidence.
This helps surgeons decide when the extra time and cost of double-row fixation is justified: reserving it for larger tears while using the faster single-row technique for small-to-medium tears.
DOMS is a near-universal complaint after unaccustomed eccentric exercise with no proven treatment, so a sham-controlled test of a passive modality like PEMF is relevant for sports medicine and rehabilitation counselling.
Cell-based injections for knee arthritis are widely marketed, so a sham-controlled trial showing a 12-month responder benefit (with a wide confidence interval and an unusual composite endpoint) is directly relevant to how you counsel patients asking about biologics.
How PRP is delivered (preparation, image guidance, rehab) may matter as much as whether it is given at all, which helps explain the conflicting PRP literature in knee osteoarthritis.
Double- versus single-bundle ACL reconstruction is a classic sports medicine debate, and this review suggests any rotational stability advantage is modest, early, and does not clearly translate into function, return to sport, or graft survival.
Frozen shoulder is extremely common and often slow to resolve with steroid injection alone, so a same-day, ultrasound-guided manipulation protocol that avoids general anaesthesia could change how orthopaedic surgeons manage refractory stiffness in the clinic.
Many patients still have pain and poor knee function years after ACL reconstruction, and this trial tests whether a structured late-stage exercise programme can help them.
Capsular management is a common decision in hip arthroscopy, and this review suggests repair matters most after larger (T-shaped) capsulotomies rather than routine interportal cuts.
Revision ACL surgery fails more often than primary reconstruction, and this adds multicentre, minimum 5-year observational support for adding a lateral extra-articular procedure to reduce re-rupture and rotational laxity.
This challenges the common reliance on limb symmetry index for return-to-sport clearance, suggesting absolute performance benchmarks and psychological readiness scores may better flag athletes at risk of ACL graft reinjury.
Surgeons often wonder whether hyperlax patients need a different graft or added lateral procedure, and this review shows the evidence for worse clinical outcomes is inconsistent and failure rates are not statistically different.
Quadriceps weakness is a major barrier to recovery and return to sport after ACL reconstruction, and NMES is a cheap, low-risk adjunct that clinicians are often unsure whether to prescribe.
Elastic bands are a cheap, portable way to add resistance training for female athletes, and hamstring strength is relevant to hamstring and ACL injury prevention, though this study did not measure injuries.
Landing mechanics like knee valgus and reduced knee flexion are linked to reinjury risk after ACL reconstruction, so trials comparing rehab strategies targeting these mechanics are directly relevant to return-to-sport planning.
Orthobiologics are often marketed to patients as a way to speed ACL graft healing, but the current randomised evidence does not show better function or tunnel healing at about 1 to 2 years.
MPFL reconstruction is the main soft-tissue operation for recurrent lateral patellar instability, and the choice between a tunnel and a bone-sparing sling for femoral fixation is a common, practical decision for sports surgeons.
Graft choice in MPFL reconstruction is a common patellofemoral instability question, and this trial suggests synthetic augmentation may speed early recovery without changing 1-year function, while long-term safety of synthetic material remains unknown.
Quadriceps tendon autograft is increasingly used for ACL reconstruction, and choosing whether to take a patellar bone block is a common intraoperative decision with trade-offs between bone healing and patellar fracture risk.
Gives clinicians and trainers an evidence-mapped catalog of exercises for targeted muscle activation in rehab and injury prevention, while exposing major gaps (e.g., piriformis, pectineus) that limit current individualized prescription.
Graft choice in combined ACL-MCL injuries is a common board and clinic question, and this study suggests the theoretical worry about hamstring harvest weakening medial dynamic restraint is not clearly borne out in short-term patient-reported outcomes.
Patients often ask about 'regenerative' knee injections, and this review supports counselling that any benefit appears symptomatic rather than cartilage-restoring, with low certainty.
It suggests that even after successful MMPR repair with good clinical outcomes, patients may retain biomechanical gait abnormalities linked to knee osteoarthritis progression, which could inform decisions about adjunct gait-modifying therapy or earlier surgical timing.
It shows that a similar 'return to sport' rate can hide a real sex gap in returning to the same level of activity after ACLR, which matters when counselling female athletes.
Losartan has been promoted as a low-cost adjunct to reduce postoperative stiffness after hip arthroscopy, so a large database study finding no measurable benefit is relevant to whether surgeons should continue prescribing it for this indication.
